As the US Food and Drug Administration's independent advisers prepare to discuss Thursday the full approval of Pfizer's Covid-19 antiviral, Paxlovid, agency experts said this week that clinical trial data shows that it is safe and effective for treatment of mild to moderate illness in high-risk adults.
#people #coronavirus #combination #million-people #president-biden #authorization #anthony-fauci #clinical-trials
[
add
]
[
|
|
...
]